177 related articles for article (PubMed ID: 32419250)
1. B-cell lymphoma 2 family genes show a molecular pattern of spatiotemporal heterogeneity in gynaecologic and breast cancer.
Wang J; Li S; Lin S; Fu S; Qiu L; Ding K; Liang K; Du H
Cell Prolif; 2020 Jun; 53(6):e12826. PubMed ID: 32419250
[TBL] [Abstract][Full Text] [Related]
2. BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Hwang KT; Kim K; Chang JH; Oh S; Kim YA; Lee JY; Jung SH; Choi IS
Cancer Res Treat; 2018 Jul; 50(3):658-669. PubMed ID: 28701032
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
Voutsadakis IA
Gene; 2023 Mar; 857():147179. PubMed ID: 36627096
[TBL] [Abstract][Full Text] [Related]
4. Role of Methylation in the Regulation of Apoptosis Genes APAF1, DAPK1, and BCL2 in Breast Cancer.
Loginov VI; Pronina IV; Burdennyi AM; Pereyaslova EA; Braga EA; Kazubskaya TP; Kushlinskii NE
Bull Exp Biol Med; 2017 Apr; 162(6):797-800. PubMed ID: 28429233
[TBL] [Abstract][Full Text] [Related]
5. SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes.
Yang Y; Wang Z; Sun L; Shao L; Yang N; Yu D; Zhang X; Han X; Sun Y
PLoS One; 2015; 10(9):e0139170. PubMed ID: 26422397
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.
Wang Y; Hao DP; Li JJ; Wang L; Di LJ
Oncotarget; 2017 Jul; 8(27):44705-44719. PubMed ID: 28621677
[TBL] [Abstract][Full Text] [Related]
7. H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency.
Svotelis A; Bianco S; Madore J; Huppé G; Nordell-Markovits A; Mes-Masson AM; Gévry N
EMBO J; 2011 Aug; 30(19):3947-61. PubMed ID: 21841772
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Thomadaki H; Talieri M; Scorilas A
Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
[TBL] [Abstract][Full Text] [Related]
9. Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.
Cui J; Placzek WJ
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361709
[TBL] [Abstract][Full Text] [Related]
10. Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer.
Bhushann Meka P; Jarjapu S; Vishwakarma SK; Nanchari SR; Cingeetham A; Annamaneni S; Mukta S; Triveni B; Satti V
Tumour Biol; 2016 May; 37(5):6905-12. PubMed ID: 26662799
[TBL] [Abstract][Full Text] [Related]
11. [The NOXA promoter could function as an active enhancer to regulate the expression of BCL2 in the apoptosis response].
Qin ZY; Shi X; Cao PP; Chu Y; Guan W; Yang N; Cheng H; Sun YJ
Yi Chuan; 2020 Nov; 42(11):1110-1121. PubMed ID: 33229317
[TBL] [Abstract][Full Text] [Related]
12. BCL2L12: a promising molecular prognostic biomarker in breast cancer.
Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A
Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343
[TBL] [Abstract][Full Text] [Related]
13. Low cleaved caspase-7 levels indicate unfavourable outcome across all breast cancers.
Lindner AU; Lucantoni F; Varešlija D; Resler A; Murphy BM; Gallagher WM; Hill ADK; Young LS; Prehn JHM
J Mol Med (Berl); 2018 Oct; 96(10):1025-1037. PubMed ID: 30069746
[TBL] [Abstract][Full Text] [Related]
14. Bcl2 and Ki67 refine prognostication in luminal breast cancers.
Chen LY; Tsang JY; Ni YB; Chan SK; Chan KF; Zhang S; Tse GM
Breast Cancer Res Treat; 2015 Feb; 149(3):631-43. PubMed ID: 25648135
[TBL] [Abstract][Full Text] [Related]
15. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
17. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
18. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
20. Chromatin accessibility associates with protein-RNA correlation in human cancer.
Sanghi A; Gruber JJ; Metwally A; Jiang L; Reynolds W; Sunwoo J; Orloff L; Chang HY; Kasowski M; Snyder MP
Nat Commun; 2021 Sep; 12(1):5732. PubMed ID: 34593797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
